▲ Peaking
Business
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
Novo Nordisk unveils its next growth engine at Capital Markets Day as competitor Eli Lilly gains ground in GLP-1s.
1 trends tracked about this subject — the full history, oldest to newest below.
Novo Nordisk unveils its next growth engine at Capital Markets Day as competitor Eli Lilly gains ground in GLP-1s.